Antibody subclass skewing predicts enhanced ADCC activity in both natural infection and vaccination

Antibody subclass skewing predicts enhanced ADCC activity in both natural infection and vaccination

Bibliographic Details
Main Authors:	Dugast A, Chung A, Chang Y, Licht A, Ackerman M, Alter G
Format:	Article
Language:	English
Published:	BMC 2012-09-01
Series:	Retrovirology

Similar Items

Vector induced skewing of antibody Fc-effector functions
by: Chung A, et al.
Published: (2012-09-01)

The Yin and Yang of ADCC-Mediating Antibodies
by: Marjorie Robert-Guroff
Published: (2016-01-01)

Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC
by: Akito Natsume, et al.
Published: (2008-12-01)

Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes
by: Pollara J, et al.
Published: (2012-09-01)

Glutaraldehyde Cross-linking of HIV-1 Env Trimers Skews the Antibody Subclass Response in Mice
by: Martina Soldemo, et al.
Published: (2017-11-01)

Determining the Phagocytic Activity of Clinical Antibody Samples
by: McAndrew, Elizabeth G., et al.
Published: (2014)

Natural killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) in tumour immunotherapy with therapeutic antibodies
by: Ursula Jördis Eva Seidel, et al.
Published: (2013-03-01)

A mathematical model of antibody-dependent cellular cytotoxicity (ADCC)
by: Hoffman, F, et al.
Published: (2017)

Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells
by: Kate J. Dixon, et al.
Published: (2021-01-01)

Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway
by: Dieter Mielke, et al.
Published: (2019-12-01)

Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood
by: Okazaki Akira, et al.
Published: (2009-02-01)

Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering
by: Sophia Roßkopf, et al.
Published: (2020-11-01)

Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
by: Grace, Patricia S, et al.
Published: (2022)

Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
by: Grace, Patricia S, et al.
Published: (2021)

Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
by: Patricia S. Grace, et al.
Published: (2021-07-01)

ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmission
by: Eleanor C. Semmes, et al.
Published: (2023-07-01)

Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother
by: Zak A. Yaffe, et al.
Published: (2023-05-01)

Development and implementation of natural killer cell simultaneous ADCC and direct killing assay
by: Maia M.C. Bennett-Boehm, et al.
Published: (2023-12-01)

“Universal Flu Vaccine”: Can NK Cell-mediated ADCC Tip the Scales?
by: Maya Hassane, et al.
Published: (2016-06-01)

ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response
by: Femke A. I. Ehlers, et al.
Published: (2021-06-01)

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection
by: Dieter Mielke, et al.
Published: (2021-11-01)

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection.
by: Dieter Mielke, et al.
Published: (2021-11-01)

KIR/HLA genotype combinations are determinants of Natural Killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) potency
by: Parsons MS, et al.
Published: (2012-09-01)

Natural Killer (NK) Cell Expression of CD2 as a Predictor of Serial Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
by: Jennifer J.-J. Tang, et al.
Published: (2020-10-01)

Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses
by: Maggie Jing Ouyang, et al.
Published: (2023-08-01)

Hypoxia‐activated ADCC‐enhanced humanized anti‐CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity
by: Fang‐Zheng Qi, et al.
Published: (2024-03-01)

The importance of antibody dependent cell-mediated cytotoxicity (ADCC) for breast cancer response to trastuzumab - Herceptin
by: Juranić Zorica D., et al.
Published: (2002-01-01)

HIV/HBV co-infection remodels the immune landscape and natural killer cell ADCC functional responses
by: Sun, B, et al.
Published: (2024)

Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity
by: Ackerman, M, et al.
Published: (2013)

Analysis of Antibody Data Using Skew-normal and Skew-T Mixture Models
by: Tiago Dias Domingues, et al.
Published: (2024-02-01)

Development of a Macrophage-Based ADCC Assay
by: Melissa B. Uccellini, et al.
Published: (2021-06-01)

Enhanced ADCC activity of affinity maturated and Fc-engineered mini-antibodies directed against the AML stem cell antigen CD96.
by: Sahar Mohseni Nodehi, et al.
Published: (2012-01-01)

Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma.
by: For Yue Tso, et al.
Published: (2021-01-01)

Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection
by: Antonio Santos-Peral, et al.
Published: (2024-02-01)

Paradox of Protection: Preferential Recognition of CD4-induced Epitopes by Anti-HIV-1 ADCC Antibodies
by: Matthew S. Parsons, et al.
Published: (2015-10-01)

V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity
by: Charmaine van Eeden, et al.
Published: (2018-12-01)

Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis
by: Marco Macagno, et al.
Published: (2022-01-01)

Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition
by: Kathleen E. Fenerty, et al.
Published: (2018-11-01)

Corrigendum: Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination
by: Sven Kratochvil, et al.
Published: (2018-02-01)

Heritability of antibody isotype and subclass responses to Plasmodium falciparum antigens.
by: Nancy O Duah, et al.
Published: (2009-10-01)